Can a light cap slow Alzheimer's? new trial tests it
NCT ID NCT06160908
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether shining near-infrared light on the head (a device called NirsCure) can safely help people with mild-to-moderate Alzheimer's disease. 38 participants will either get real light or a sham treatment for 16 weeks, then everyone can get the real light for up to 196 weeks. The goal is to see if this light therapy can slow down memory and thinking problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- near-infrared light therapy (device)
- What this could lead to
- If it works, this could offer a non-drug way to slow cognitive decline in Alzheimer's disease.
- What could go wrong
- This is a small, early-stage trial with only 38 people. The effect may be small or no better than placebo, and long-term benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospital, Capital Medical University
Beijing, 100053, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?